Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Sequentify
company
About
Sequentify develops sample processing technologies and solutions for next-generation sequencing, genomic diagnostics, and therapeutics.
- 1 - 10
Highlights
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $7M
- Industries
- Health Care,Health Diagnostics,Medical Device
- Founded date
- Jan 1, 2021
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Sequentify provides a technology that is based on tools from the synthetic biology and AI software worlds for targeted DNA sequencing applications such as cancer diagnostics, carrier screening, COVID-19 surveillance and other applications.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$7M
Sequentify has raised a total of
$7M
in funding over 2 rounds. Their latest funding was raised on
Oct 31, 2022 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 31, 2022 | Grant | — | 1 |
National Institutes of Health
|
— | Detail |
| May 10, 2022 | Seed | $7M | 1 |
OurCrowd
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
Sequentify is funded by 2 investors.
National Institutes of Health
and OurCrowd
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
|
OurCrowd
|
Yes | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
